Dosimetry for radiolabelled antibodies--macro or micro?

Area of Science:

• Medical Physics
• Radiation Oncology
• Radiopharmaceutical Therapy

Background:

• Accurate radiation dosimetry is crucial for effective radiolabeled antibody therapy.
• Understanding dose distribution at the cellular and tissue level is essential for optimizing treatment and minimizing toxicity.
• Current dosimetry methods face challenges in addressing the small-scale volumes relevant to targeted therapies.

Purpose of the Study:

• To evaluate different approaches for calculating radiation absorbed doses in radiolabeled antibody therapy.
• To determine the suitability of various dosimetry methods for small-scale tissue and tumor volumes.
• To identify the most practical and applicable dosimetry technique for current therapeutic applications.

Main Methods:

• Review and comparison of three dosimetry approaches: macroscopic dosimetry, beta particle dosimetry, and microdosimetry.
• Assessment of the applicability of each method to small-scale normal tissue and tumor volumes.
• Evaluation of the practical relevance of each method for radiolabeled antibody therapy.

Main Results:

• Conventional macroscopic dosimetry is deemed inappropriate for the small volumes relevant to therapy.
• Beta particle dosimetry is identified as a more traditional and suitable approach, applicable down to small cell populations.
• Microdosimetry, while theoretically relevant, is considered too far from practical application for current use.

Conclusions:

• Beta particle dosimetry provides a viable method for calculating absorbed doses in radiolabeled antibody therapy at the cellular level.
• Macroscopic dosimetry is inadequate for the fine-scale dose calculations needed in targeted therapies.
• Further development is needed for microdosimetry to become practically applicable in this field.